Altre lingue Hyper Corporation Inc.

Azioni

A065650

KR7065650004

Prezzo di chiusura Korea S.E. Altri mercati azionari 00:00:00 03/05/2024			Variaz. 5gg	Var. 1 gen.
1.480 ^KRW	+0,07%		+2,42%	+50,56%

28/03

FSN Co., Ltd. (KOSDAQ:A214270), AI Tech Fund, Asset Plus Fund e Open Innovation Fund, gestiti da Benex Investment, hanno completato l'acquisizione di una partecipazione del 22,4% in Medifron DBT Co. (KOSDAQ:A065650) da Hansung Cleantech Co., Ltd. (KOSDAQ:A065650). (KOSDAQ:A066980) e T Scientific Co.,Ltd. (KOSDAQ:A057680)

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Medifron DBT Co., Ltd. announced that it has received KRW 20.999999826 billion in funding from FSN Co., Ltd.	26/04
Medifron DBT Co., Ltd. agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd..	05/04
AdQUA Interactive Inc. agreed to acquire 48% stake in Emotion Global, Inc. from Medifron DBT Co., Ltd. for KRW 5.9 billion.	05/04
Medifron DBT Co., Ltd. agreed to acquire 19.49% stake in Makeus Co.,Ltd. from FSN Co., Ltd. for KRW 7.9 billion.	05/04
FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment completed the acquisition of a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd.	28/03
EN Creative Co., Ltd. agreed to acquire HMR business of Medifron DBT Co., Ltd. for KRW 5.7 billion	16/02
Medifron DBT Co., Ltd. announced that it expects to receive KRW 41.999999652 billion in funding	15/02
Medifron DBT Co., Ltd. announced that it expects to receive KRW 20.999999826 billion in funding from FSN Co., Ltd.	15/02
Medifron DBT Co., Ltd. announced that it has received KRW 4.0000092 billion in funding from T Scientific Co.,Ltd	14/12/22
Medifron DBT Co., Ltd.(KOSDAQ:A065650) dropped from S&P Global BMI Index	19/09/22
Medifron DBT Co., Ltd. announced that it has received KRW 3 billion in funding	24/08/22
Medifron DBT Co., Ltd. announced that it expects to receive KRW 3 billion in funding	22/08/22
Medifron DBT Co., Ltd. announced that it has received KRW 5 billion in funding from Shinhan Financial Investment Co., Ltd., Mirae Asset Securities Co. Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd.	30/06/22
Medifron DBT to Raise $3.9 Million via Stock Offering	22/06/22
Medifron DBT to Raise $10 Million via Stock Offering	22/06/22
Medifron DBT Co., Ltd. announced that it expects to receive KRW 5 billion in funding from Shinhan Financial Investment Co., Ltd., Mirae Asset Securities Co. Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd.	22/06/22
Medifron DBT Co., Ltd. announced that it expects to receive KRW 12.9999915 billion in funding from Best Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd., Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd. and other investors	22/06/22
Medifron DBT Co., Ltd. announced that it expects to receive KRW 4.9999995 billion in funding from T Scientific Co.,Ltd	22/06/22
Medifron DBT Co., Ltd. announced that it has received KRW 4 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm	15/09/21
Medifron DBT Co., Ltd. announced that it expects to receive KRW 4 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm	13/09/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Hyper Corporation Inc.

Azioni

A065650

KR7065650004

Altre lingue

Filtri